Improving the Diagnosis and Treatment of Patients With Hypertriglyceridemia: Practical Strategies for the Primary Care Physician

Activity Description & Educational Objectives

In this activity, experts in cardiovascular disease prevention discuss challenges in the diagnosis and initial treatment of patients with hypertriglyceridemia, as well as strategies for lipid management in the patient with persistent high triglycerides.

Upon completion of this activity, participants should be better able to:

• Discuss the most recent evidence-based guidelines for the detection, evaluation, and treatment of hypertriglyceridemia, identifying significant changes from the previous version
• Discuss screening strategies for hypertriglyceridemia, focusing on the importance of early and accurate diagnosis
• Evaluate the benefits and limitations of available and emerging therapeutic options for patients with persistent high triglycerides
• Implement individualized treatment plans in accordance with recent clinical findings and evidence-based recommendations for the diagnosis and management of hypertriglyceridemia

Target Audience

This activity has been designed to meet the educational needs of primary care physicians and other clinicians involved in the management of patients with hypertriglyceridemia.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Internet
Release and Expiration Dates: February 20, 2013 - February 19, 2014
Time to Complete: 30 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, Penn State College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director and Moderator

Christie M. Ballantyne, MD
Professor of Medicine
Chief, Section of Cardiovascular Research
Chief, Section of Cardiology
Don W. Chapman M.D. Endowed Chair of Cardiology
Department of Medicine
Baylor College of Medicine
Director, Center for Cardiovascular Disease Prevention
Baylor College of Medicine and Methodist DeBakey Heart Center
Houston, Texas

Christie M. Ballantyne, MD, has a financial interest/relationship or affiliation in the form of:

Consultant for Abbott Laboratories; Adnexus, a Bristol-Myers Squibb R&D Company; Amarin Pharma Inc.; Bristol-Myers Squibb Company; Cerenis Therapeutics; Esperion Therapeutics, Inc.; Genentech, Inc.; GlaxoSmithKline; Hoffmann-La Roche Inc.; Idera Pharmaceuticals; Kowa Pharmaceuticals America, Inc.; Merck & Co., Inc.; Novartis Corporation; Omthera Pharmaceuticals, Inc.; Pfizer Inc.; Resverlogix Corp.; Sanofi-Synthelabo; and Takeda Pharmaceutical Company Limited.

Grant/Research Support from Abbott Laboratories; ADA; Amarin Pharma Inc.; American Heart Association; AstraZeneca; Bristol-Myers Squibb Company; Genentech, Inc.; GlaxoSmithKline; Hoffmann-La Roche Inc.; Merck & Co., Inc.; National Institutes of Health; Novartis Corporation; Sanofi-Synthelabo; and Takeda Pharmaceutical Company Limited. All paid to the institution, not the individual.

Speakers Bureau participant with Abbott Laboratories and GlaxoSmithKline.

Honoraria from Abbott Laboratories; Adnexus, a Bristol-Myers Squibb R&D Company; Amarin Pharma Inc.; AstraZeneca; Bristol-Myers Squibb Company; Cerenis Therapeutics; Esperion Therapeutics, Inc.; Genentech, Inc.; GlaxoSmithKline; Hoffmann-La Roche Inc.; Idera Pharmaceuticals; Kowa Pharmaceuticals America, Inc.; Merck & Co., Inc.; Novartis Corporation; Omthera Pharmaceuticals, Inc.; Resverlogix Corp.; Sanofi-Synthelabo; and Takeda Pharmaceutical Company Limited.

Interviewee

Michael Miller, MD, FACC, FAHA
Professor
Departments of Medicine, Epidemiology & Public Health
University of Maryland School of Medicine
Director, Center for Preventive Cardiology
University of Maryland Medical Center
Baltimore, Maryland

Michael Miller, MD, FACC, FAHA, has a financial interest/relationship or affiliation in the form of:

Consultant for Abbott Laboratories; Amarin Pharma Inc.; and Lupin Pharmaceuticals, Inc.

Grant/Research Support from Amarin Pharma Inc.

CME Reviewer

John P. Boehmer, MD
Professor of Medicine and Surgery
Division of Cardiology
Penn State College of Medicine
Hershey, Pennsylvania

John P. Boehmer, MD, has a financial interest/relationship or affiliation in the form of:

Consultant for Boston Scientific Corporation; Medtronic, Inc.; and St. Jude Medical, Inc.

Grant/Research Support from St. Jude Medical, Inc.

Medical Director

Christopher Washburn, PhD
PVI, PeerView Institute for Medical Education

Christopher Washburn, PhD, currently has no financial interests/relationships or affiliations in relation to this activity.

Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.

Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.

Sponsorship, Credit & Support

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Penn State College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course # G5255-14-T.

This CME activity is jointly sponsored by Penn State College of Medicine and PVI, PeerView Institute for Medical Education.

This activity is supported by an educational grant from

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.